Table 2.

Percentages of viable, apoptotic and necrotic cells after 24, 48, and 72 h treatment.

MDA-MB-231 cells and Treatment	Viable cells (%)	Early Apoptotic (%)	Late Apoptotic (%)	Necrotic (%)
Untreated cells after 24 h	93.17 ± 0.88	2.33 ± 0.17	1.67 ± 0.67	2.33 ± 0.33
MEDL treated cells after 24 h	75.83 ± 0.88a	8.17 ± 0.44a	10.67 ± 0.33ab	5.50 ± 0.50ab
5-FU treated cells after 24 h	68.33 ± 0.44	27.83 ± 0.60	2.17 ± 0.17	1.33 ± 0.33
Untreated cells after 48 h	88.83 ± 0.73	4.17 ± 0.44	3.33 ± 0.17	3.67 ± 0.33
MEDL treated cells after 48 h	64.17 ± 1.17a	8.67 ± 0.88a	11.17 ± 0.93a	16.00 ± 0.58ab
5-FU treated cells after 48 h	48.67 ± 1.36	34.83 ± 0.73	13.17 ± 1.33	3.33 ± 0.44
Untreated cells after 72 h	84.33 ± 0.44	6.83 ± 0.17	3.50 ± 0.50	5.33 ± 0.17
MEDL treated cells after 72 h	46.67 ± 0.60a	11.83 ± 0.33a	17.50 ± 0.87a	24.00 ± 0.58a
5-FU treated cells after 72 h	42.00 ± 0.29	12.17 ± 0.60	17.67 ± 0.44	28.17 ± 0.44

Data are presented as mean ± standard error (n = 3).

^aStatistically significant (p < 0.05) compared to the untreated cells.

^bStatistically significant (p < 0.05) compared to the 5-FU treated cells.